National Brain Tumor Society Partners with National Foundation for Cancer Research on Glioblastoma Multiforme (GBM) Brain Cancer Initiative

Share Article

Collaboration will aim to drive the development of new brain cancer therapies

National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, announced a collaborative funding partnership with the National Foundation for Cancer Research (Bethesda, MD). This collaboration will allow the organizations to create a unique effort to drive the development of targeted new brain cancer therapies. More specifically the organizations will focus their efforts for glioblastoma multiforme (GBM), the deadliest of all brain tumors.

Today, 688,000 Americans are living with a primary brain tumor, and over 66,000 more will be diagnosed this year. Brain tumors are the second leading cause of cancer-related death in children under the age of 20. Only one out of three adults diagnosed with a malignant brain tumor today will be alive in five years. And, more so than any other cancer, a brain tumor can have life-altering and long-term psychological, cognitive, behavioral, and physical effects.

“To work with an organization like the National Foundation for Cancer Research which has broad expertise in research affecting all types of cancer will deliver helpful insights and valuable resources to our focused brain cancer collaboration,” said N. Paul TonThat, Executive Director, National Brain Tumor Society. “We have big gaps that need to be addressed; more research and organizational partnerships are required to overcome these deficiencies which slow progress in therapy development. And, we’re confident we can be more powerful together,” said TonThat.

“Collaboration among nonprofits is vital to progress, and we at NFCR are committed to help push this research initiative forward by partnering with the National Brain Tumor Society," said Franklin Salisbury, Jr., President of the National Foundation for Cancer Research. “This is an innovative collaboration between two cancer-related charities, a partnership poised to deliver results that will create better outcomes for brain cancer patients,” said Salisbury.

Additional details regarding this strategic collaboration, as well as complete project descriptions and research goals will be announced later in 2013.

About National Brain Tumor Society
National Brain Tumor Society (NBTS) is the largest nonprofit organization dedicated to the brain tumor community in the United States. We are fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and those who will be diagnosed tomorrow. This means aggressively driving strategic research and advocating for public policies, which meet the critical needs of this community. To learn more visit

About National Foundation for Cancer Research
The National Foundation for Cancer Research (NFCR) is a leading charity dedicated to funding cancer research and public education relating to cancer prevention, earlier diagnosis, better treatments and, ultimately, cures for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside.

Since 1973, NFCR has provided over $300 million in direct support of discovery-oriented cancer research focused on understanding how and why cells become cancerous, and on public education relating to cancer prevention, detection, and treatment. NFCR scientists are discovering cancer's molecular mysteries and translating these discoveries into therapies that hold the hope for curing cancer. NFCR is about Research for a Cure-cures for all types of cancer. For more information, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Alison Bengel
National Brain Tumor Society
(617) 393-2841
Email >